SIGN UPLog In

General

Financials

Activity

Recent News

Last deal

$81.72M
Local Amount - EUR 75M

Amount

Series A

Stage

23.01.2024

Date

1

all rounds

$81.72M

Total amount

date founded

Financing round

General

About Company
Calluna Pharma is developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source.

Also Known As

Calluna, Arxx Therapeutics, Oxitope Pharma

founded date

2024

Number of employees

11-50

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Calluna has developed a robust pipeline of selective antibodies, targeting immunological diseases. These include novel therapeutic candidates that fulfill unmet clinical needs across a spectrum of diseases.
Contacts

location

Oslo, Norway

Contact Email

Website URL

https://www.callunapharma.com

Social url

Legal Names

Legal name

Calluna Pharma Inc.

Financials

Funding Rounds
1
1

Number of Funding Rounds

$81.72M

Money Raised

Their latest funding was raised on 23.01.2024. Their latest investor p53. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
23.01.2024
Series A
4
$81.72M
Local Amount - EUR 75M
—
Co-Investors
Investors
4
0

Number of lead investors

4

Number of investors

Investor 
Lead 
Round 
Partners 
p53
No
Series A
Susanne Stuffers
Susanne Stuffers
Forbion
Forbion
No
Series A
Antoine Boulanger
Antoine Boulanger
Investinor
Investinor
No
Series A
—

p53

P53 is a venture capital firm that focuses on backing groundbreaking healthcare companies.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Biotechnology, Health Care, Medical Device

count Of Investments

2
Susanne Stuffers

Susanne Stuffers

Susanne Stuffers is a mentor at Creative Destruction Labs.

current job

Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL)
Forbion

Forbion

Netherlands-based venture capital firm investing in life sciences and MedTech companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Naarden, Netherlands

count Of Investments

165

count Of Exists

68
Antoine Boulanger

Antoine Boulanger

Co-Founder and CEO at Okay.

current job

Okay
Okay
Investinor

Investinor

Investinor is a Norwegian venture capital firm with $500m in assets.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Finance

Location

Trondheim, Norway

count Of Investments

115

count Of Exists

13

Activity

Recent News
0